This is exactly why I'm a broken record about physician-supervised weight loss rather than the mail-order, fire-and-forget approach
Dr Malige pointed to patent timelines and said, Semaglutide will go out of patency in March 2026 after that, leading Indian pharmaceutical companies will manufacture and market semaglutide, which will bring down the cost significantly. $499 in the U.S., 17,000 in India: The Cost of Chasing the Skinny Jab Dream Patent expiry matters
When ferritin stored iron is released it is reduced back to the ferrous state
Everything was explained well
Both medications share some common side effects, including nausea, vomiting, diarrhea, and potential gastrointestinal discomfort, especially when starting treatment